← New search
Phenotype profile

colorectal cancer

SaudiVarKB evidence summary derived from retained literature mentions.

523Phenotype mentions
100Publications
50Associated gene records
50Associated variant records

Associated gene records

Co-mentioned in the same publications
GeneIdentifier / contextArticlesMentions
KRASHGNC:64073939
TP53HGNC:119982929
BRAFHGNC:10972828
EGFRHGNC:32362222
APCHGNC:5832121
PIK3CAHGNC:89751616
PTENHGNC:95881515
MLH1HGNC:71271414
MSH2HGNC:73251010
NRASHGNC:79891010
PMS2HGNC:912299
MSH6HGNC:732999
BAXHGNC:95999
BCL2HGNC:99066
CTNNB1HGNC:251466
ATMHGNC:79566
BRCA2HGNC:110166
GSTM1HGNC:463266
STAT3HGNC:1136455
BRCA1HGNC:110055
CCND1HGNC:158255
GSTP1HGNC:463855
LDHAHGNC:653555
PCNAHGNC:872955
MUTYHHGNC:752755
IMPACTHGNC:2038744
MMP2HGNC:716644
CD44HGNC:168144
ATRHGNC:88244
IDH1HGNC:538244
MYCHGNC:755344
CCND3HGNC:158544
ERBB2HGNC:343044
ABCC1HGNC:5144
XRCC1HGNC:1282844
RETNHGNC:2038944
ABCB1HGNC:4033
CXCL8HGNC:602533
NOTCH1HGNC:788133
PALB2HGNC:2614433
SMAD4HGNC:677033
GSTT1HGNC:464133
MDM2HGNC:697333
CLDN2HGNC:204133
ABCE1HGNC:6933
EPCAMHGNC:1152933
CYP1A1HGNC:259533
PRNCR1HGNC:4894233
PARP1HGNC:27022
CDK4HGNC:177322

Associated variant records

Co-mentioned in the same publications
VariantIdentifier / contextArticlesMentions
V600EV600E22
rs1042522rs104252222
rs1136201rs113620122
rs11571317rs1157131722
p.G12Dp.G12D22
p.G13Dp.G13D22
S33FS33F22
C677TC677T11
A1298CA1298C11
rs1800896rs180089611
rs1800629rs180062911
rs731236rs73123611
rs2228570rs222857011
rs1544410rs154441011
rs7975232rs797523211
rs1544410rs154441011
rs731236rs73123611
p.W577Cp.W577C11
G894TG894T11
p.Ala771Glyp.Ala771Gly11
p.Val797Glyp.Val797Gly11
rs1800469rs180046911
rs2228570rs222857011
rs231775rs23177511
rs1264457rs126445711
rs383369rs38336911
rs7247538rs724753811
rs7975232rs797523211
V600EV600E11
E49RE49R11
G10RG10R11
E37KE37K11
Q61KQ61K11
Q61*Q61*11
rs76011559rs7601155911
rs12273047rs1227304711
rs1695rs169511
rs1138272rs113827211
rs701848rs70184811
rs2735343rs273534311
G12DG12D11
E49KE49K11
R102QR102Q11
G138EG138E11
V600EV600E11
W151CW151C11
L272PL272P11
A296SA296S11
A330DA330D11
R391HR391H11

Associated population records

Co-mentioned in the same publications
PopulationIdentifier / contextArticlesMentions
Saudi Arabia3535
Saudi ArabiaCohort 10066
Population recordCohort 14255
Population recordCohort 2033
Saudi ArabiaCohort 1033
Saudi ArabiaCohort 11533
Population recordCohort 10033
Population recordCohort 4633
Population recordCohort 6522
Population recordCohort 1822
Population recordCohort 2122
Population recordCohort 5322
Saudi ArabiaCohort 6022
Population recordCohort 222
Population recordCohort 522
Population recordCohort 822
Population recordCohort 12022
Saudi ArabiaCohort 14422
Population recordCohort 9822
Saudi ArabiaCohort 12522
Population recordCohort 51922
Population recordCohort 9,25422
Saudi ArabiaCohort 8322
Saudi Arabia · JeddahCohort 6022
Population recordCohort 1711
Population recordCohort 13511
Population recordCohort 4311
Population recordCohort 1011
Population recordCohort 711
Population recordCohort 95011
Population recordCohort 111
Saudi Arabia · Riyadh11
Population recordCohort 4711
Population recordCohort 5911
Saudi ArabiaCohort 22011
Population recordCohort 4011
Population recordCohort 8011
Population recordCohort 611
Population recordCohort 28511
Population recordCohort 411
Saudi ArabiaCohort 2411
Population recordCohort 3811
Population recordCohort 24711
Population recordCohort 10211
Saudi Arabia · Jeddah11
Saudi ArabiaCohort 2611
Saudi ArabiaCohort 2711
Population recordCohort 15211
Population recordCohort 1,30011
Population recordCohort 50011

Supporting publications

100 records
  1. 2026Deciphering Mutational Impacts on c-Src-HK2 Interaction in Colorectal Cancer Progression, and Identification of Potential Phytocompounds Inhibitors: A Molecular Simulation and Free Energy Calculation Approach.Current medicinal chemistry1 mentions
  2. 2026AQP9 and IFITM1 as drivers of immune infiltration and tumor progression in IBD-associated colorectal cancer: from computational insights to experimental validation.Naunyn-Schmiedeberg's archives of pharmacology1 mentions
  3. 2026Oral and Maxillofacial Manifestations of Gardner Syndrome: A Literature Analysis.The Journal of craniofacial surgery1 mentions
  4. 2026Pharmacophore-based high-throughput virtual screening (HTVS) to identify new c-Src kinase inhibitors with anticancer potential.Bioorganic & medicinal chemistry1 mentions
  5. 2026Disruption of NANOG-driven epithelial-mesenchymal transition (EMT) and self-renewal restores drug sensitivity in colorectal cancer.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy1 mentions
  6. 2026Benchmarking pathology foundation models for predicting microsatellite instability in colorectal cancer histopathology.Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society1 mentions
  7. 2026CRISPR/Cas9-mediated claudin-2 knockout in HCT116 cells reveals its key role in colorectal cancer progression.Oncology letters1 mentions
  8. 2026Study of the association of LILRB2 gene polymorphisms with colorectal cancer susceptibility and prognosis in Tunisian population.Human immunology1 mentions
  9. 2026Unveiling Tamarix articulata phytochemicals as novel natural inhibitors of colon cancer: A holistic drug design and toxicological approach.Journal of molecular graphics & modelling1 mentions
  10. 2026HLA-E gene polymorphism and expression in colorectal cancer patients.Human immunology1 mentions
  11. 2026Synthesis, characterization, and anticancer evaluation of N-Heterocyclic entities: ADME profiling and In Silico predictions.Toxicology reports1 mentions
  12. 2026Compact deep learning models for colon histopathology focusing performance and generalization challenges.Scientific reports1 mentions
  13. 2026Analysis of Risk Factors and Assessment of miRNA-122 as a Novel Biomarker for Colon Cancer in Egyptian Patients.Asian Pacific journal of cancer prevention : APJCP1 mentions
  14. 2026Profound alterations of cancer transcriptomes by the RNase L inhibitor ABCE1 through the modulation of UU/UA-dinucleotide rich transcript abundance.RNA biology1 mentions
  15. 2026Cubosomal nanoparticles of lycopene as a novel platform for enhancement in antioxidant and anticancer properties with a molecular docking study.Scientific reports1 mentions
  16. 2026EGFR as a biomarker in colorectal Cancer: An electrochemical biosensing approach.Clinica chimica acta; international journal of clinical chemistry1 mentions
  17. 2026Unlocking the Role of Exosomal ncRNAs in Colorectal Cancer: Molecular Insights and Clinical Promise.Current pharmaceutical design1 mentions
  18. 2026Poliovirus receptor (PVR) expression as a predictor of relapse in colorectal cancer: bioinformatics and virtual screening.Experimental biology and medicine (Maywood, N.J.)1 mentions
  19. 2026Pericytes and mesenchymal stromal cells converge toward pro-tumor phenotypes in the tumor microenvironment.Discover oncology1 mentions
  20. 2026KRAS Variant Frequency and Colorectal Cancer-Specific Survival by Race and Ethnicity.JAMA network open1 mentions
  21. 2026The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection.Ecancermedicalscience1 mentions
  22. 2026Bioactivity-Guided Fractionation of the Bidah Pomegranate Landrace Identifies a Bioactive Fraction Inducing Mitochondria-Associated Apoptotic Responses in Colorectal Cancer Cells.International journal of molecular sciences1 mentions
  23. 2026Deciphering the Molecular Interactions of Tuberculosis and Colorectal Cancer: A Network and RNA-Seq Data Analysis Approach.Anti-cancer agents in medicinal chemistry1 mentions
  24. 2026Clinical Discovery and Molecular Analysis of Two Novel MSH2 Gene Mutations (p.Ala771Gly and p.Val797Gly) in Saudi Colorectal Cancer Patients: Potential Implications for Tumorigenesis.Health science reports1 mentions
  25. 2026A comprehensive analysis of the Cullin family reveals that CUL5 and CUL7 promote colorectal cancer progression and serve as prognostic markers.Hereditas1 mentions
  26. 2026Integrative Multi-Omics and Molecular Simulations Identify PRKCD as a Biological Modulator in Colon Adenocarcinoma: Validation With Phoenix dactylifera Phytochemicals and Comparison With Rottlerin.Chemical biology & drug design1 mentions
  27. 2026Metal accumulation in paired colon cancer and adjacent tissues and its relationship with genotoxic and epigenetic biomarkers.Frontiers in public health1 mentions
  28. 2026Fucosylation Dynamics as a Critical Determinant of Cancer Cell Fate in Colorectal Carcinoma: Integrating Hallmark Plasticity, Microenvironmental Remodelling, and Therapeutic Resistance.Biology1 mentions
  29. 2026The Colorectal Cancer Glycocode: Tumour Sialylation Is Associated with an Immune-Excluded Phenotype and Distinct Therapeutic Signatures.Biology1 mentions
  30. 2026N-Substituted-2-(9H-Xanthen-9-yl)acetamide Derivatives Induce In Vitro Colon Cancer Cell Death via TASK-1 Inhibition: Lead Compounds for Further Optimization as TASK-1-Targeted Therapeutics in Colorectal Cancer.International journal of molecular sciences1 mentions
  31. 2026The ATP-adenosine axis as a driver of tumor-associated macrophage reprogramming in colorectal cancer: mechanistic insights into immune evasion and therapeutic vulnerabilities.Purinergic signalling1 mentions
  32. 2026Comparative molecular analysis of colorectal cancer in Saudi Arabia: distinct genetic alterations and clinical features.Frontiers in oncology1 mentions
  33. 2026Molecular and Immune Profiling of Sessile Serrated Adenomas/Polyps Reveals Prognostic Genes and Immune Cell Dynamics in Colorectal Cancer Progression.Applied biochemistry and biotechnology1 mentions
  34. 2026Modulating claudin-2 with CRISPR-Cas9 to improve photodynamic therapy outcomes in colorectal cancer.Tissue & cell1 mentions
  35. 2026Targeting DNMT1 restores PTEN expression in colorectal cancer cells.Molecular and cellular probes1 mentions
  36. 2026A QbD optimization of a pH-responsive Eudragit S100-chitosan nanoformulation for the co-delivery of pentoxifylline and simvastatin in colorectal cancer therapy.RSC advances1 mentions
  37. 2026Efficient colorectal cancer classification from histopathological images utilizing lightweight convolutional neural networks.Computers in biology and medicine1 mentions
  38. 2026O-Glycosylation Signatures Shape the Tumour Immune Microenvironment and Associate with Genomic Stability, Drug Resistance Programmes, and Epithelial Differentiation in Colorectal Cancer.Pharmaceuticals (Basel, Switzerland)1 mentions
  39. 2026Tissue-Agnostic Targeting in Solid Tumors: A PRISMA-Compliant Meta-Analysis of Efficacy, Safety, and Resistance Determinants Across Histologies.Oncology research1 mentions
  40. 2026Green synthesis of ZnO/Fe3O4 nanocomposites from Citrus reticulata peel: antibacterial activity against MDR Acinetobacter baumannii, CRISPR-Cas gene modulation, and anticancer potential.RSC advances1 mentions
  41. 2026Irisin Potentiates 5-fluorouracil Cytotoxicity in HT-29 Colon Cancer Cells through Enhanced Apoptosis and Transcriptional Modulation of Adenosine Monophosphate-activated Protein Kinase/Mammalian Target of Rapamycin Signaling.International journal of applied & basic medical research1 mentions
  42. 2026Liposomal honokiol attenuates dimethylhydrazine-induced colon carcinogenesis in rats through modulation of oxidative stress, inflammation, apoptosis, autophagy, and lipid metabolism pathways.Medical oncology (Northwood, London, England)1 mentions
  43. 2025Genomic Landscape of Advanced Solid Tumors in Middle East and North Africa Using Circulating Tumor DNA in Routine Clinical Practice.Oncology1 mentions
  44. 2025Prevalence of SPOP and IDH Gene Mutations in Prostate Cancer in a Jordanian Population.Biochemical genetics1 mentions
  45. 2025Visible-light-induced CO-releasing properties and cytotoxicity of a Ru(II) carbonyl complex containing 2-(pyridin-2-yl)-quinoxaline.Dalton transactions (Cambridge, England : 2003)1 mentions
  46. 2025Investigation of GSTP1 and PTEN gene polymorphisms and their association with susceptibility to colorectal cancer.Radiology and oncology1 mentions
  47. 2025Targeting the Hippo and Rap1 signaling pathways: the anti-proliferative effects of curcumin in colorectal cancer cell lines.Medical oncology (Northwood, London, England)1 mentions
  48. 2025A review on the effects of flavan-3-ols, their metabolites, and their dietary sources on gut barrier integrity.Food & function1 mentions
  49. 2025Relationship between inherited genetic variation and survival from colorectal cancer stratified by tumour location.Scientific reports1 mentions
  50. 2025Schiff bases targeting an Sw-480 colorectal cell line: synthesis, characterization, ds-DNA binding and anticancer studies.RSC advances1 mentions
  51. 2025The mutational spectrum of NRAS gene discovers a novel frameshift mutation (E49R) in Saudi colorectal cancer patients.Cancer cell international1 mentions
  52. 2025Discovery of PPAR Alpha Lipid Pathway Modulators That Do Not Bind Directly to the Receptor as Potential Anti-Cancer Compounds.International journal of molecular sciences1 mentions
  53. 2025Nutraceutical Impact of Pumpkin Seed Oil on Expression Levels of EZH-2 and KRT-14 Genes against DSS-induced Inflammatory Bowel Disease in the Rat Model.Cell biochemistry and biophysics1 mentions
  54. 2025First Case of Tracheobronchopathia Osteochondroplastica in an 82-Year-Old Patient From Saudi Arabia.Laryngoscope investigative otolaryngology1 mentions
  55. 2025The incidence of venous thromboembolism by type of solid cancer worldwide: A systematic review.Cancer epidemiology1 mentions
  56. 2025A Computational Recognition Analysis of Promising Prognostic Biomarkers in Breast, Colon and Lung Cancer Patients.International journal of molecular sciences1 mentions
  57. 2025Association of Genetic Liability to Allergic Diseases with Overall and Early-Onset Colorectal Cancer Risk: A Mendelian Randomization Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology1 mentions
  58. 2025Chitosan-Coated Silver Nanourchins for Imatinib Mesylate Delivery: Biophysical Characterization, In-Silico Profiling, and Anti-Colon Cancer Efficacy.Molecular pharmaceutics1 mentions
  59. 2025Discovery of a selective PI3Kα inhibitor via structure-based virtual screening for targeted colorectal cancer therapy.Journal of enzyme inhibition and medicinal chemistry1 mentions
  60. 2025Deciphering the anticancer potential of thymoquinone: in-depth exploration of the potent flavonoid from Nigella sativa.Molecular biology reports1 mentions
  61. 2025Unraveling molecular interconnections and identifying potential therapeutic targets of significance in obesity-cancer link.Journal of the National Cancer Center1 mentions
  62. 2025Exploring potential additive effects of 5-fluorouracil, thymoquinone, and coenzyme Q10 triple therapy on colon cancer cells in relation to glycolysis and redox status modulation.Journal of the Egyptian National Cancer Institute1 mentions
  63. 2025Costs of Adverse Event Management Associated with First-Line Cetuximab or Panitumumab in Metastatic Colorectal Cancer Patients in Saudi Arabia.Journal of health economics and outcomes research1 mentions
  64. 2025Dissociation between the expression of cGAS/STING and a senescence-associated signature in colon cancer.International journal of immunopathology and pharmacology1 mentions
  65. 20256-Paradol enhances sorafenib's effects against colorectal cancer and promotes active metabolite formation.Pathology, research and practice1 mentions
  66. 2025Recent Update of Natural Compounds as HIF-1α Inhibitors in Colorectal Carcinoma.Drug design, development and therapy1 mentions
  67. 2025Vitexin's Role in Colon Cancer Apoptosis: AMPK/mTOR Pathway Modulation Explored Through Experimental and Computational Approaches.Recent patents on anti-cancer drug discovery1 mentions
  68. 2025Probiotics in colorectal cancer prevention and therapy: mechanisms, benefits, and challenges.Discover oncology1 mentions
  69. 2025Flavonoids and their role in oxidative stress, inflammation, and human diseases.Chemico-biological interactions1 mentions
  70. 2025Exploration of mRNA-modifying METTL3 oncogene as momentous prognostic biomarker responsible for colorectal cancer development.Open medicine (Warsaw, Poland)1 mentions
  71. 2025Effectiveness of Tumor-induced Mesenchymal Stem Cells on Cell Growth and Development in Different Cancer Types In Vitro and In Vivo Models.Archives of medical research1 mentions
  72. 2025New alkanesulfonate-based quinazolinone-acetohydrazide scaffolds: Rational design, synthesis, molecular docking, anticancer properties and potential EGFR and its T790M/L858R mutants inhibitors.Bioorganic chemistry1 mentions
  73. 2025Isolation, Screening, and Identification of Staphylococcus epidermidis with Effective Probiotic Attributes.Current microbiology1 mentions
  74. 2025Exploring the molecular pathways of advanced rectal cancer: A focus on genetic, RNA, and biological technique.Pathology, research and practice1 mentions
  75. 2025Artificial intelligence in inflammatory bowel disease.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  76. 2025Zapotin mitigates breast cancer progression by targeting PKCε mediated glycolytic pathway regulation.BMC cancer1 mentions
  77. 2025Increased protein expression of interleukin-10 and its signalling molecules in colon cancer progression: potential prognostic and therapeutic targets.Discover oncology1 mentions
  78. 2025Dynamic comprehensive learning-based dung beetle optimizer using triangular mutation for polyps image segmentation.Computational biology and chemistry1 mentions
  79. 2025Anthocyanins: From Natural Colorants to Potent Anticancer Agents.Food science & nutrition1 mentions
  80. 2025The gastrointestinal mycobiome in inflammation and cancer: unraveling fungal dysbiosis, pathogenesis, and therapeutic potential.Medical oncology (Northwood, London, England)1 mentions
  81. 2025Incidental low-grade appendiceal mucinous neoplasm in Crohn's disease patient post ileocecal resection: a case report.Journal of surgical case reports1 mentions
  82. 2025Propranolol and Capecitabine Synergy on Inducing Ferroptosis in Human Colorectal Cancer Cells: Potential Implications in Cancer Therapy.Cancers1 mentions
  83. 2025Expression Profile of Serum CircFUNDC1 and CircUHRF1 Can Differentiate Between Colorectal Cancer and Inflammatory Bowel Diseases (Ulcerative Colitis and Crohn's Disease).Journal of clinical laboratory analysis1 mentions
  84. 2025Synergistic Inhibition of Colon Cancer Cell Proliferation via p53, Bax, and Bcl-2 Modulation by Curcumin and Plumbagin Combination.ACS omega1 mentions
  85. 2025Ileal pouch-anal anastomosis in familial adenomatous polyposis and ulcerative colitis with coexisting colorectal cancer: a guideline for treatment.Journal of surgical case reports1 mentions
  86. 2025Triazole-quinoxaline attenuates epithelial-to-mesenchymal transition by suppressing the Wnt/β-catenin pathway in human colorectal cancer cells.Archives of biochemistry and biophysics1 mentions
  87. 2025Comparative in silico analyses between Lactiplantibacillus plantarum and Bifidobacterium longum concerning probiotic properties, anti-lipidemic, and anti-diabetic in vitro activities.BMC microbiology1 mentions
  88. 2025Imiquimod-Loaded Phospholipid-Free Small Unilamellar Vesicles Activate the Tumor Immune Microenvironment to Treat Liver Cancer and Liver Metastases.Advanced healthcare materials1 mentions
  89. 2025Effects of PIK3CA Gene Modifications on Radiosensitivity in Colorectal Cancer Cells.Asian Pacific journal of cancer prevention : APJCP1 mentions
  90. 2025Probiotics and Cancer: Mechanistic Insights and Organ-Specific Impact.Biomolecules1 mentions
  91. 2025PARP Inhibition in Colorectal Cancer-A Comparison of Potential Predictive Biomarkers for Therapy.Pharmaceuticals (Basel, Switzerland)1 mentions
  92. 2025In-silico analysis of potential phytochemicals targeting mitogen activating protein kinase-14 (MAPK14) gene in colorectal cancer.Scientific reports1 mentions
  93. 2025Investigating the genetic landscape of cancer in Jordan: a step toward personalized care.European journal of medical research1 mentions
  94. 2025Phyto-Fabrication Tribulus terrestris Mediated Iron Oxide Nanoparticles: A Promising Approach of Antioxidant and Anticancer Activities via in vitro and in silico Studies.Frontiers in bioscience (Landmark edition)1 mentions
  95. 2025The Significance of STAT3 in Colonic Diseases: A Comprehensive Study of Pathological Roles and Therapeutic Implications.Cell biochemistry and biophysics1 mentions
  96. 2025ABCE1 facilitates tumour progression via aerobic glycolysis and inhibits cell death in human colorectal cancer cells through the p53 signalling pathway.Scientific reports1 mentions
  97. 2025USP6NL knockdown suppresses colorectal cancer progression by inducing CASP9-Mediated apoptosis and disrupting FOXC2/SNAI1-Driven EMT and angiogenesis.Functional & integrative genomics1 mentions
  98. 2025Utilizing of Seaweed for Eco-friendly Synthesis of Nickel Cobalt Nanoparticles and Assessment of its Cytotoxic Effects on Human Liver and Colon Cancer Cells.Dose-response : a publication of International Hormesis Society1 mentions
  99. 2025A Comprehensive Review on the Molecular Mechanism of Lycopene in Cancer Therapy.Food science & nutrition1 mentions
  100. 2025Long-Term Survival for Locally Advanced Adenosquamous Carcinoma Colon Cancer in Ulcerative Colitis: A Case Report.Case reports in oncology1 mentions